Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis
Authors
Keywords
-
Journal
Clinical Epidemiology
Volume Volume 15, Issue -, Pages 923-937
Publisher
Informa UK Limited
Online
2023-09-04
DOI
10.2147/clep.s418069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19
- (2023) Susanna Naggie et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Contribution of an extensive medication-based comorbidity index (Rx-Risk) in explaining the excess mortality after hip fracture in older Norwegians: a NOREPOS cohort study
- (2022) Kristin Holvik et al. BMJ Open
- Antibiotic Prescribing in Dutch Daytime and Out-of-Hours General Practice during the COVID-19 Pandemic: A Retrospective Database Study
- (2022) Karin Hek et al. Antibiotics-Basel
- Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia
- (2022) Andrea L. Schaffer et al. PLoS One
- Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns
- (2022) Dimitra S. Mouliou et al. Diagnostics
- Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study
- (2022) Clément Mathieu et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
- (2022) Muthiah Vaduganathan et al. LANCET
- Drug utilization patterns before and during COVID-19 pandemic in Manitoba, Canada: A population-based study
- (2022) Laila Aboulatta et al. PLoS One
- Prophylaxis for COVID-19: a systematic review
- (2021) Mikaela Smit et al. CLINICAL MICROBIOLOGY AND INFECTION
- Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review
- (2021) Bruno Silva Andrade et al. Frontiers in Pharmacology
- Trends in Prescribing of Antibiotics and Drugs Investigated for COVID-19 Treatment in U.S. Nursing Home Residents During the COVID-19 Pandemic
- (2021) Katryna A Gouin et al. CLINICAL INFECTIOUS DISEASES
- Impact of COVID-19 on corticosteroids and antibiotics prescribing in England: an interrupted time series analysis
- (2021) Christos V Chalitsios et al. JOURNAL OF PUBLIC HEALTH
- Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by US Retail Pharmacies During the Pandemic
- (2021) Andrew I. Geller et al. JAMA Internal Medicine
- A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)
- (2021) Thomas Hale et al. Nature Human Behaviour
- Impact of the COVID-19 Pandemic on Antibiotic Prescribing for Common Infections in The Netherlands: A Primary Care-Based Observational Cohort Study
- (2021) Alma C. van de Pol et al. Antibiotics-Basel
- Increased dispensing of prescription medications in Australia early in the COVID‐19 pandemic
- (2021) Mustafa Mian et al. MEDICAL JOURNAL OF AUSTRALIA
- Prophylaxis against covid-19: living systematic review and network meta-analysis
- (2021) Jessica J Bartoszko et al. BMJ-British Medical Journal
- Changes in antibiotic prescribing following COVID‐19 restrictions: Lessons for post‐pandemic antibiotic stewardship
- (2021) Malcolm B. Gillies et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A Cross-Sectional Analysis
- (2021) Jennifer N. Lind et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 Outbreak Impact on Anticoagulants Utilization: An Interrupted Time-Series Analysis Using Health Care Administrative Databases
- (2021) Ippazio Cosimo Antonazzo et al. THROMBOSIS AND HAEMOSTASIS
- Estimates of COVID-19 Risk Factors among Social Strata and Predictors for a Vulnerability to the Infection
- (2021) Dimitra S. Mouliou et al. International Journal of Environmental Research and Public Health
- COVID‐19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims Data
- (2021) Inmaculada Hernandez et al. Journal of the American Heart Association
- Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19
- (2021) Alex C. Spyropoulos et al. JAMA Internal Medicine
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System
- (2018) Nicole L Pratt et al. BMJ Open
- The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges
- (2013) Sipke T Visser et al. Expert Review of Pharmacoeconomics & Outcomes Research
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started